Boocock D.J., Faust G.E., Patel K.R., Schinas A.M., Brown V.A., Ducharme M.P., Booth T.D., Crowell J.A., Perloff M., Gescher A.J., Steward W.P., Brenner D.E. (2007) Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 16:1246-52 PubMed (17548692)

Urine analysed without enzymatic deconjugation

Show related metabolites from the same publication

Cumulative Excretion in Urine (% of dose)
Number Dose Multiple Dose Duration Time (hours) Polyphenol Source
Name as described in publication
0 2 4 8 12 24
1 0.5 g Single Dose 0 3.8 7.6 10.4 11.4 11.5
resveratrol
Chart?cht=lxy&chs=600x300&chf=bg,s,fafafa&chxt=x,x,y&chxr=0,0.0,24.240000000000002,2|2,0.0,11.615,1&chds=0.0,24.240000000000002,0.0,11.615&chxl=1:|time+after+ingestion+(hours)&chtt=cumulative+excretion+in+urine+(%+of+dose)&chxp=1,50|3,50&chd=t:0.0,2.0,4.0,8.0,12.0,24.0|0.0,3.8,7.6,10.4,11.4,11